Advertisement

Pathology of Cardiac Complications in HIV Infection

  • G. Barbaro

Abstract

The prevalence of myocardial abnormalities in HIV-infected patients ranges from 25 to 75% [1]. This wide range probably reflects differences in methodology, patients’ risk factors, disease stage, and environmental factors such as drug addiction or therapeutic agents. Myocardial involvement in HIVinfected patients includes dilated cardiomyopathy, myocarditis, ischemic heart disease, and neoplastic invasion from HIV-associated malignancies (e.g., non-Hodgkin’s lymphoma or Kaposi’s sarcoma). In addition, the right ventricle can be involved as a consequence of AIDS-related pulmonary disease.

Keywords

Infective Endocarditis Pericardial Effusion Intravenous Drug Abuser Actinobacillus Actinomycetemcomitans Fungal Endocarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G and the Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators (1998) Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14:1071–7107CrossRefPubMedGoogle Scholar
  2. 2.
    D’Amati G, Di Gioia CRT, Gallo P (2001) Pathological findings of HIV-associated cardiovascular disease. Ann NY Acad Sci 946:23–45PubMedGoogle Scholar
  3. 3.
    Klatt EC (2003) Cardiovascular pathology in AIDS. Adv Cardiol 40:23–48CrossRefPubMedGoogle Scholar
  4. 4.
    Aretz HT (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619–624CrossRefPubMedGoogle Scholar
  5. 5.
    Barbaro G, Di Lorenzo G, Soldini M et al (1999) Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Circulation 100:933–939PubMedGoogle Scholar
  6. 6.
    Herskowitz A, Tzyy-Choou W, Willoughby SB et al (1994) Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24:1025–1032PubMedCrossRefGoogle Scholar
  7. 7.
    Barbaro G, Barbarini G, Pellicelli AM (2001) HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med 344:1799–1800CrossRefPubMedGoogle Scholar
  8. 8.
    Twu C, Liu QN, Popik W et al (2002) Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion and death receptor-controlled pathways. Proc Natl Acad Sci USA 99:14386–14391CrossRefPubMedGoogle Scholar
  9. 9.
    Barbaro G, Klatt EC (2003) Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients. Curr Pharm Des 9:1475–1481CrossRefPubMedGoogle Scholar
  10. 10.
    Holmberg SD, Moorman AC, Williamson JM et al (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360:1747–1748CrossRefPubMedGoogle Scholar
  11. 11.
    Barbaro G, Di Lorenzo G, Cirelli A et al (2003) An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV receiving highly active antiretroviral therapy. Clin Ther 25:2405–2418CrossRefPubMedGoogle Scholar
  12. 12.
    Friis-Moller N, Weber R, Reiss P et al (2003) Cardiovascular risk factors in HIV patients: association with antiretroviral therapy. Results from DAD study. AIDS 17:1179–1193Google Scholar
  13. 13.
    Bozzette SA, Ake CF, Tam HK et al (2003) Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348:702–710CrossRefPubMedGoogle Scholar
  14. 14.
    The Data Collection on Adverse Events of AntiHIV Drugs (DAD) Study Group (2003). Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349:1993–2003CrossRefGoogle Scholar
  15. 15.
    Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G and the Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS investigators (1998) Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14:1071–1077CrossRefPubMedGoogle Scholar
  16. 16.
    Duong M, Dubois C, Buisson M et al (1997) NonHodgkin’s lymphoma of the heart in patients infected with human immunodeficiency virus. Clin Cardiol 20:497–502CrossRefPubMedGoogle Scholar
  17. 17.
    Sanna P, Bertoni F, Zucca E et al (1998) Cardiac involvement in HIV-related non-Hodgkin’s lymphoma: a case report and short review of the literature. Ann Hematol 77:75–78CrossRefPubMedGoogle Scholar
  18. 18.
    Dal Maso L, Serraino D, Franceschi S (2001) Epidemiology of HIV-associated malignancies. Cancer Treat Res 104:1–18Google Scholar
  19. 19.
    Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92:3229–3234PubMedGoogle Scholar
  20. 20.
    Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40:282–284CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • G. Barbaro
    • 1
  1. 1.Department of Medical Pathophysiology“Sapienza” University of RomeRomeItaly

Personalised recommendations